Impax Laboratories (IPXL) Tops Q2 EPS by 3c, Revenue Beats Expectations
Tweet
Share
E-mailGet Alerts IPXL Hot Sheet
Price: $18.30 --0%
Financial Fact:
Total revenues: 227.91M
Today's EPS Names:
DGICA, UXIN, TOWN, More
Financial Fact:
Total revenues: 227.91M
Today's EPS Names:
DGICA, UXIN, TOWN, More
Join SI Premium – FREE
Impax Laboratories (NASDAQ: IPXL) reported Q2 EPS of $0.22, $0.03 better than the analyst estimate of $0.19. Revenue for the quarter came in at $125.9 million versus the consensus estimate of $110.94 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hermes (HESAY) reports 'solid sales growth' in Q1
- WNS Holdings (WNS) Tops Q4 EPS by 6c, provides guidance
- Xcel Energy (XEL) Tops Q1 EPS by 8c, Misses on Revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
